Cargando…
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
Angiotensin converting enzyme 2 (ACE2) (EC:3.4.17.23) is a transmembrane protein which is considered as a receptor for spike protein binding of novel coronavirus (SARS-CoV2). Since no specific medication is available to treat COVID-19, designing of new drug is important and essential. In this regard...
Autores principales: | Basu, Anamika, Sarkar, Anasua, Maulik, Ujjwal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573581/ https://www.ncbi.nlm.nih.gov/pubmed/33077836 http://dx.doi.org/10.1038/s41598-020-74715-4 |
Ejemplares similares
-
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021) -
Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020) -
Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex
por: Isaac-Lam, Meden F.
Publicado: (2021) -
Searching Remote Homology with Spectral Clustering with Symmetry in Neighborhood Cluster Kernels
por: Maulik, Ujjwal, et al.
Publicado: (2013) -
An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2–Spike complex of SARS-CoV-2 using computational methods
por: Jani, Vinod, et al.
Publicado: (2021)